Liebenberg LJP, Passmore JS, Osman F, Jewanraj J, Mtshali A, Garcia-Lerma JG, et al. Genital immune cell activation and tenofovir gel efficacy: a case-control study. Clin Infect Dis. 2022.
Genital immune cell activation and tenofovir gel efficacy: a case-control study
By Peter Matlawa|2022-05-31T10:31:35+02:00May 31, 2022|2022 Publication, 2022: January to March|Comments Off on Genital immune cell activation and tenofovir gel efficacy: a case-control study
Share This Story, Choose Your Platform!
About the Author: Peter Matlawa
Related Posts
Correction for Kipkorir et al., “De Novo Cobalamin Biosynthesis, Transport, and Assimilation and Cobalamin-Mediated Regulation of Methionine Biosynthesis in Mycobacterium smegmatis”
Correction for Kipkorir et al., “De Novo Cobalamin Biosynthesis, Transport, and Assimilation and Cobalamin-Mediated Regulation of Methionine Biosynthesis in Mycobacterium smegmatis”
Recency of HIV infection, antiretroviral therapy use and viral loads among symptomatic sexually transmitted infection service attendees in South Africa